These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18726097)

  • 1. Analysis of reactivation of hepatitis B virus in the treatment of B cell non-Hodgkin's lymphoma in Hokkaido.
    Tsutsumi Y; Shigematsu A; Hashino S; Tanaka J; Chiba K; Masauzi N; Kobayashi H; Kurosawa M; Iwasaki H; Morioka M; Asaka M; Imamura M
    Ann Hematol; 2009 Apr; 88(4):375-7. PubMed ID: 18726097
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reactivation of hepatitis B virus due to rituximab plus CHOP after preemptive lamivudine administration in a patient with diffuse large B-cell lymphoma].
    Ono K; Iyama S; Matsunaga T; Sato T; Sato Y; Okuda T; Takada K; Kawano Y; Hayashi T; Miyanishi K; Sagawa T; Kobune M; Takimoto R; Kato J; Niitsu Y
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1509-12. PubMed ID: 17876158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma.
    Perceau G; Diris N; Estines O; Derancourt C; Lévy S; Bernard P
    Br J Dermatol; 2006 Nov; 155(5):1053-6. PubMed ID: 17034541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal reactivation of hepatitis B after chemotherapy for lymphoma.
    Dillon R; Hirschfield GM; Allison ME; Rege KP
    BMJ; 2008 Jul; 337():a423. PubMed ID: 18595895
    [No Abstract]   [Full Text] [Related]  

  • 5. Late reactivation of resolved hepatitis B virus infection: an increasing complication post rituximab-based regimens treatment?
    Garcia-Rodriguez MJ; Canales MA; Hernandez-Maraver D; Hernandez-Navarro F
    Am J Hematol; 2008 Aug; 83(8):673-5. PubMed ID: 18528824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV-positive status and hepatitis flares in patients with B-cell non-Hodgkin's lymphoma treated with rituximab-containing regimens.
    Marignani M; Mangone M; Cox MC; Angeletti S; Veggia B; Ferrari A; di Fonzo M; Begini P; Gigante E; Laverde G; Aloe-Spiriti A; Monarca B; Delle Fave G
    Dig Liver Dis; 2011 Feb; 43(2):139-42. PubMed ID: 20554488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis.
    Koo YX; Tan DS; Tan BH; Quek R; Tao M; Lim ST
    J Clin Oncol; 2009 May; 27(15):2570-1; author reply 2571-2. PubMed ID: 19364951
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma.
    Cheson BD; Leonard JP
    N Engl J Med; 2008 Aug; 359(6):613-26. PubMed ID: 18687642
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
    Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
    J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fulminant hepatitis B following rituximab therapy in a patient with Evans syndrome and large B-cell lymphoma.
    Ozgönenel B; Moonka D; Savaşan S
    Am J Hematol; 2006 Apr; 81(4):302. PubMed ID: 16550511
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
    J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma.
    Uchiyama M; Tamai Y; Ikeda T
    Int J Infect Dis; 2010 Mar; 14(3):e265-6. PubMed ID: 19665406
    [No Abstract]   [Full Text] [Related]  

  • 13. Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma.
    Yang SH; Kuo SH
    Ann Hematol; 2008 Apr; 87(4):325-7. PubMed ID: 17932671
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenging problems in advanced malignancy: Case 1. Chylopericardium during the treatment of non-Hodgkin's lymphoma.
    Lee YH; Im SA; Nam SH; Lee SN; Kim Y; Seong CM; Han WS; Lee SW; Park SH; Lee SN
    J Clin Oncol; 2003 Aug; 21(16):3168-70. PubMed ID: 12915608
    [No Abstract]   [Full Text] [Related]  

  • 15. Telbivudine use in a patient affected by occult hepatitis B virus and B-cell non-Hodgkin lymphoma.
    Montineri A; Nigro L; Chiarenza A; Larocca L; La Rosa R; Iacobello C; Di Raimondo F; Fatuzzo F
    Leuk Lymphoma; 2010 Mar; 51(3):554-7. PubMed ID: 20141445
    [No Abstract]   [Full Text] [Related]  

  • 16. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
    Huang H; Cai Q; Lin T; Lin X; Liu Y; Gao Y; Peng R
    Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of infantile non-Hodgkin's lymphoma].
    Bernacer Borja M
    An Esp Pediatr; 1990 Nov; 33 Suppl 43():149-54. PubMed ID: 2103986
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety analysis of rituximab combined with chemotherapy in the treatment of B-cell lymphoma patients complicated with hepatitis B virus infection.
    Wang S; Zhang Z; Cai H; Wang Y
    Indian J Cancer; 2016; 53(3):443-447. PubMed ID: 28244480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis-B reactivation and rituximab-containing chemotherapy: an increasingly complex clinical challenge.
    Thompson PA; Tam CS; Thursky K; Seymour JF
    Leuk Lymphoma; 2010 Sep; 51(9):1592-5. PubMed ID: 20807092
    [No Abstract]   [Full Text] [Related]  

  • 20. Rational combinations of enzastaurin with novel targeted agents for patients with B-cell non-Hodgkin's lymphoma.
    Civallero M; Cosenza M; Bari A; Sacchi S
    Expert Opin Investig Drugs; 2011 Aug; 20(8):1029-31. PubMed ID: 21702717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.